ClinVar Miner

Submissions for variant NM_002691.4(POLD1):c.2360C>T (p.Pro787Leu)

gnomAD frequency: 0.00004  dbSNP: rs199783227
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000235244 SCV000294014 uncertain significance not provided 2018-01-15 criteria provided, single submitter clinical testing This variant is denoted POLD1 c.2360C>T at the cDNA level, p.Pro787Leu (P787L) at the protein level, and results in the change of a Proline to a Leucine (CCG>CTG). This variant has not, to our knowledge, been published in the literature as a germline variant; however, it has been reported as a somatic variant in a colorectal cancer and other cancer(s) of unspecified type (Palles 2013, Campbell 2017). POLD1 Pro787Leu was not observed at a significant allele frequency in large population cohorts (Lek 2016). This variant is located in the Polymerase domain (Preston 2010). In-silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function. Based on currently available evidence, it is unclear whether POLD1 Pro787Leu is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.
Invitae RCV000705985 SCV000835012 uncertain significance Colorectal cancer, susceptibility to, 10 2023-11-30 criteria provided, single submitter clinical testing This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 787 of the POLD1 protein (p.Pro787Leu). This variant is present in population databases (rs199783227, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with POLD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 246453). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt POLD1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
PreventionGenetics, part of Exact Sciences RCV003907909 SCV004725115 uncertain significance POLD1-related condition 2023-11-05 criteria provided, single submitter clinical testing The POLD1 c.2360C>T variant is predicted to result in the amino acid substitution p.Pro787Leu. To our knowledge, this variant has not been reported as a germline variant in the literature. This variant is reported in 0.029% of alleles in individuals of European (Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/19-50917108-C-T) and is interpreted as uncertain significance in ClinVar (www.ncbi.nlm.nih.gov/clinvar/variation/246453). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.